SiRNA technology, the gene therapy of the future?;SiRNS-technológia, a jövo génterápiája?

Orvosi Hetilap

Volumn 149, Issue 4, 2008, Pages 153-159

  Rácz, Zsuzsanna ^a   Hamar, Péter ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Delivery; Human gene therapy; RNA interference (RNAi); Short interfering RNA (siRNA)

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON; SMALL INTERFERING RNA; VIRUS VECTOR;

CATHETERIZATION; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; HEMODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; MAMMAL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; RNA INTERFERENCE; RNA STRUCTURE; VIRAL GENE DELIVERY SYSTEM;

EID: 39349086980     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28289     Document Type: Review

References (50)

1. Milhavet, O., Gary, D. S., Mattson, M. P.: Pharmacol. Rev., RNA Interference in Biology and Medicine. 2003, 55, 629-648.
2. www.clinicaltrials.gov.ghv.nlm.nih.gov
3. Devroe, E., Silver, P. A.: Therapeutic potential of retroviral RNAi vectors. Expert Opin. Biol. Ther., 2004, 4, 319-327.
4. Vaucheret H., Beclin C., Fegard M. J.: Post-transcriptional gene silencing in plants. Cell Sci., 2001, 114, 3083-3091.
5. Agrawal, N., Malhotra, P., Bhatnayar, R. K.: siRNA-directed silencing of transgene expressed in cultured insect cells. Biochem. Biophys. Res. Commun., 2004, 320, 428-434.
6. Napoli, C., Lemieux, C., Jorgensen, R.: Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell, 1990, 2, 279-289.
7. Grishok, A., Mello, C. C.: RNAi (nematodes: Ceanorhabditis elegans). Adv. Genet., 2002, 46, 339-360.
8. Hammond, S. M., Berstein, E., Beach, D. és mtsa: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 2000, 404, 293-296.
9. Elbashir, S. M., Harboth, J., Lendeckel, W. és mtsai: Duplexes of 21-nt RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411, 494-498.
10. Fire, A., Xu, S., Montgomery, M. K. és mtsai: Potent and specific genetic interference by doubte-stranded RNA in Caenorhabditis elegans, Nature, 1998, 391, 806-811.
11. Kennerdell, J. R., Carthew, R. W.: Use of ds-RNA mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell, 1998, 95, 1017-1026.
12. Lohmann, J. U., Endl, I., Bosch, T. C.: Silencing of developmental genes in Hydra. Dev. Biol., 1999, 214, 211-214.
13. Wargelius, A., Ellingsen, S., Fjose, A.: Double-stranded RNA induces specific developmental defects in zebrafish embryos. Biochem. Biophys. Res. Commun., 1999, 263, 156-161.
14. Song, E., Lee, S. K., Wang, J. és mtsai: RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Medicine, 2003, 9, 347-351.
15. Hamar, P., Song, E., Kökény, G. és mtsai: Small interfering RNA targeting Fas protects mice from renal ischemia-reperfusion injury. PNAS, 2004, 101, 14883-14888.
16. Gou, D., Narasaraju, T., Reddy, N. és mtsai: Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo. Nucleic Acids Res., 2004, 32, 134.
17. Kumar, M., Carmichael, G. G.: Antisense RNA: function and fate of duplex RNA in higher eukaryotes. MMBR, 1998, 62, 1415-1434.
18. Zamore, P. D., Tuschl, T., Sharp, P. és mtsa: RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 2000, 101, 25-33.
19. McCaffrey, A. P., Meuse, L., Pham, T. T. és mtsai: RNA interference in adult mice. Nature, 2002, 418, 38-39.
20. Simeoni, F., Morris, M. C., Heutz, F.: Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNAs into mammalian cells. Nucleic Acids Res., 2003, 31, 2717-2724.
21. Vorburger, S. A., Hunt, K. K.: Adenoviral gene therapy. The Oncologist, 2002, 7, 46-59.
22. Bessis, N., GarciaCozar, F. J. Boissier, M. C.: Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Therapy, 2004, 11, 10-17.
23. Gao, G. P., Yang, Y., Wilson, J. M.: Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol., 1996, 70, 8934-8943.
24. Benrt, K., Liang, M., Ye, X. és mtsai: A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication. J. Virol., 2002, 76, 10994-11002.
25. Samulski, R. J., Zhu, X., Xiao, X. és mtsai: Targeted integration of adeno-associated virus (AAV) into human chromosome 19. The EMBO Journal, 1991, 17, 3941-3950.
26. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M. és mtsai: LMO2-associated clonal Tcell proliferation in two patients after gene therapy for SCID-X1. Science, 2003, 302, 400-419.
27. Davidson, B. L., Paulson, H. L.: Molecular medicine for the brain: silencing of deisease genes with RNA interference. Lancet Neurol., 2004, 3, 145-149.
28. Reich, S. J., Fosnot, J., Kuroki, A. és mtsai: Small interfering RNA (siRNA) targeting VEGF efficiently inhibits ocular neovascularization in a mouse model. J. Molecular Vision, 2003, 9, 210-216.
29. Flynn, M. A., Casey, D. G., Todryk, S. M. és mtsa: Efficient delivery of small interfering RNA for inhibition of IL- 12p4O expression in vivo. J. Inflamm. (Lond)., 2004, 1, 4-16.
30. Paddison, P. J., Caudy, A. A., Bernstein, E. -aces mtsai: Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev., 2002, 16, 948-958.
31. Bonnet, M. C., Weil, R., Dam, E. és mtsai: PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex. Mol. Cell. Biol., 2000, 20, 4532-4542.
32. Kumar, M., Carmichael, G. G.: Antisense RNA: function and fate of duplex RNA in higher eukaryotes. Microbiol. Mol. Biol. Rev., 1998, 62, 1415-1434.
33. Sledz, C. A., Holko, M., Veer, M. J. és mtsai: Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol., 2003, 5, 834-839.
34. Fish, R. J., Kruithof, E. K. O.: Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol. Biol., 2004, 5, 9-24.
35. Scacheri, P. C., Rozenblatt-Rosen, O., Caplan, N. J. és mtsai: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. PNAS, 2004, 101, 1892-1897.
36. Walters, D. K., Jelinek, D. F.: The Effectiveness of Double-Stranded Short Inhibitory RNAs (siRNAs) May Depend on the Method of Transfection. Antisense Nucleic Acid Drug Dev., 2002, 12, 411-418.
37. Jackson, A. L., Bartz, S. R., Schelter, J. és mtsai: Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology, 2003, 21, 635-637.
38. Reiley, W., Zhang, M., Wu, X. és mtsai: Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation. Mol. Cell. Biol., 2005, 25, 3886-3895.
39. Kapaida, S. B., Brideau-Andersen, A., Chisari, F. V.: Interference of hepatitis C virus RNA replication by short interfering RNAs Proc. Natl. Acad. Sci. USA, 2003, 100, 2014-2018.
40. Wang, Z., Ren, L., Zhao, X. és mtsai: Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells. J. Virol., 2004, 78, 7523-7527.
41. Ge, Q., Filip, L., Bai, A. és mtsai: Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA, 2004, 101, 8676-8681.
42. Song, E., Lee, S. K., Dykxhoorn, D. M. és mtsai: Sustained Small Interfering RNA-Mediated Human Immunodeficiency Virus Type 1 Inhibition in Primary Macrophages. J. Virol., 2003, 77, 7174-7181.
43. Vieira, O. V, Harrison, R. E., Scott, C. C. és mtsai: Acquisition of Hrs, an Essential Component of Phagosomal Maturation, Is Impaired by Mycobacteria. Mol. Cell. Biol., 2004, 24, 4593-4604.
44. Liang, X. H., Liu, Q., Michaeli, S.: Small nucleolar RNA interference induced by antisense or double-stranded RNA in trypanosomatids. Proc. Natl. Acad. Sci. USA, 2003, 100, 7521-7526.
45. Schiffelers, R. F., Ansari, A., Xu, J. és mtsai: Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res., 2004, 32, 149-159.
46. Boado, R. J.: RNA Interference and Nonviral Targeted Gene Therapy of Experimental Brain Cancer. NeuroRX, 2005, 2, 139-150.
47. Onodera, Y., Hashimoto, S., Hashimoto, A. és mtsai: Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. The EMBO Journal, 2005, 24, 963-973.
48. Menendez, J. A., Vellon, L., Mehmi, I. és mtsai: Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. PNAS USA, 2004, 101, 10715-10720.
49. Miller, V. M., Gouvion, C. M., Davidson, B. L. és mtsa: Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res., 2004, 32, 661-668.
50. Dou, F., Netzer, W. J., Tanemura, K. és mtsai: Chaperones increase association of tau protein with microtubules. Proc. Nati. Acad. Sci. USA, 2003, 100, 721-726.